JP Morgan takes DME stake

The exchange’s board issued a stake of up to 20% to strategic investors in early August. JP Morgan now joins firms such as Goldman Sachs, Morgan Stanley and Vitol as stakeholders. CME Group / Nymex, Tatweer, a member of Dubai Holding, and the Oman Investment Fund collectively hold a 75% equity stake in the exchange.

“The addition of JP Morgan to our newly extended group of shareholders continues to reflect the industry’s confidence in the DME and its value proposition,” said DME CEO Tom Leav

To continue reading...

You must be signed in to use this feature.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: